• Editors
  • About Us
  • Our Supporters
  • Contact Us
  • Subscribe Now!
  • Home
  • Articles
  • News
  • Announcements
  • Events
  • Letters

Trending Topics

  • Insurance and Risk Management
  • Outsourcing
  • E-discovery
  • Campaign Finance Law
  • Elections
  • National Association Of Corporate Directors
  • Regulation
  • Corporate-Securities
  • Compliance Programs
  • Delaware
  • Alien Tort Claims Act
  • Partnering with Law Firms and Service Providers
  • Defense Counsel Organizations
  • Judicial Compensation
  • Corporate Securities and Finance
more Topics
Home

Healthcare-Life Sciences

Biotech-Pharma Innovation Requires Specialized Patent Counsel
Basil S. Krikelis
McCarter & English, LLP
Buyers And Sellers Beware – Federal And State Antitrust Authorities Heighten Scrutiny Of Healthcare Provider M&A
Scott B. Murray
Sills Cummis & Gross P.C.
Science And The Law Are Equal Partners In IP Practice
Steven G. Davis
McCarter & English, LLP
The FDA’s Efforts To Regulate Dietary Supplements, Then And Now
Theodora McCormick
Sills Cummis & Gross P.C.
Six Important Strategies To Reduce The Royalty Burden For A Pharmaceutical Product
Lori M. Waldron
Sills Cummis & Gross P.C.
Syndicate content

Disclaimer • Privacy
The Metropolitan Corporate Counsel, Inc. 1180 Wychwood Road, Mountainside, NJ 07092.
Contact us at info@metrocorpcounsel.com 
© 2012The Metropolitan Corporate Counsel, Inc. All rights reserved.